Boothbay Fund Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,795
| Closed | -$204K | – | 1324 |
|
|
2024
Q3 | $204K | Sell |
2,795
-358
| -11% | -$26.2K | ﹤0.01% | 1206 |
|
|
2024
Q2 | $183K | Buy |
3,153
+358
| +13% | +$20.8K | ﹤0.01% | 1147 |
|
|
2024
Q1 | $2.89M | Buy |
+2,795
| New | +$2.89M | 0.06% | 318 |
|
|
2023
Q2 | – | Sell |
-1,131
| Closed | -$798K | – | 1574 |
|
|
2023
Q1 | $798K | Buy |
1,131
+393
| +53% | +$277K | 0.02% | 914 |
|
|
2022
Q4 | $756K | Sell |
738
-284
| -28% | -$291K | 0.02% | 836 |
|
|
2022
Q3 | $593K | Buy |
+1,022
| New | +$593K | 0.01% | 997 |
|